Cheng‐Han Tsai
Papers
1
Total Citations
12
H-Index
1
About
Dr. Cheng‐Han Tsai is a distinguished urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques, particularly robotic-assisted partial nephrectomy for renal tumors. His major contributions lie in identifying and characterizing risk factors for postoperative complications, with a specific focus on hemorrhagic events following robotic kidney surgery. Dr. Tsai’s landmark 2023 study, which analyzed a cohort of 260 patients, has garnered 12 citations and provides critical clinical guidance for preoperative risk stratification and intraoperative decision-making. By systematically examining patient demographics, tumor characteristics, and surgical variables, his research helps surgeons anticipate and mitigate bleeding risks, ultimately improving patient safety and surgical outcomes. Beyond this pivotal work, Dr. Tsai’s broader portfolio explores the intersection of surgical innovation and patient-centered care, contributing to the growing evidence base that supports robotic approaches as safe and effective alternatives to traditional open or laparoscopic nephrectomy. His findings are increasingly referenced in urologic literature and clinical guidelines, reflecting their practical impact on surgical practice. Dr. Tsai’s dedication to refining surgical techniques and enhancing recovery pathways marks him as a thoughtful contributor to the evolution of modern urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1